D. Blakey
Cancer Research · 2013
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Whom D. Blakey trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Rakesh K. Jain (in Biomedical Engineering)
Papers from D. Blakey's perspective
Ordered by how strongly the researchers D. Blakey trusts endorse each paper. Same corpus, a different order for every researcher.
- Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. (Journal of Clinical Oncology)
- Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile (Science Translational Medicine)
- Delivering nanomedicine to solid tumors (Nature Reviews Clinical Oncology)
- Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy (Proceedings of the National Academy of Sciences of the United States of America)
- Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin signaling (Cell)
- High-speed optical frequency-domain imaging. (Optics Express)
- Myofibroblasts and mechano-regulation of connective tissue remodelling (Nature reviews. Molecular cell biology)
- Clearance Properties of Nano-sized Particles and Molecules as Imaging Agents: Considerations and Caveats (Nanomedicine)
- Tumour biology: Herceptin acts as an anti-angiogenic cocktail (Nature)
- Pathology: Cancer cells compress intratumour vessels (Nature)